Health & Medical · Week of Oct 26, 2026
Clinics, home dialysis and employer programs widen care access
Expanded care access led the week: two Florida vein clinics, a home dialysis program and a broader employer health contract, plus a new Abbott cancer test.
Several releases this week were about extending care to more patients or new settings. United Vein & Vascular Centers opened two Florida clinics on Oct. 26, 2026, in Brandon and Vero Beach. Vantive outlined plans to expand its HomeAdvantage home dialysis offering, and DarioHealth Corp. added a women's health program to an existing employer contract with a regional grocery retailer.
In diagnostics, Abbott launched a whole-genome sequencing version of its Oncodetect molecular residual disease test. Other items were corporate and market news: 111, Inc. named advisers to its special committee, Boston Scientific Corporation set a conference appearance, and MarketsandMarkets issued a patient registry software market forecast.
Abbott
Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment
Abbott launched a next-generation Oncodetect molecular residual disease test using whole-genome sequencing and MAESTRO technology, which the company says tracks up to 5,000 patient-specific variants with a limit of detection below one part per million under high-end inputs. The test is intended to detect traces of cancer during and after treatment.
DarioHealth Corp.
Dario Expands Contract with a Leading Regional Grocery Retailer, Adding Women's Digital Health and Clinical Care Program
DarioHealth Corp. says it expanded its contract with a regional grocery retailer to add its women's digital health and clinical care program, after benefits from its cardiometabolic program and employee demand for perimenopause support. The company says nearly 45% of its current book of business is women over age 40 who could potentially benefit from Dario Women.
111, Inc.
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
111, Inc. (NASDAQ: YI) announced that its special committee of three independent directors has appointed an independent financial advisor and legal counsel. The release, dated Oct. 26, 2026, was issued from Shanghai.
Boston Scientific Corporation
Boston Scientific to participate in Stifel's 2026 Healthcare Conference
Boston Scientific Corporation (NYSE: BSX) will participate in Stifel's 2026 Healthcare Conference on Wednesday, November 11, 2026. Kenneth Stein, M.D., senior vice president and global chief medical officer, and Lance Bates, an executive vice president, are named as participants.
MarketsandMarkets
Patient Registry Software Market worth $3.99 billion by 2031 - Exclusive Report by MarketsandMarkets™
MarketsandMarkets projects the patient registry software market will reach USD 3.99 billion by 2031, up from USD 2.47 billion in 2026. That equals a CAGR of 10.0% over the forecast period, according to the firm.
United Vein & Vascular Centers
United Vein & Vascular Centers Opens Brandon Vein Clinic, Expanding Access Across Eastern Hillsborough County
United Vein & Vascular Centers opened a vein clinic at 517 Eichenfeld Dr., Suite 106, Brandon, FL 33511, which began seeing patients on Oct. 26, 2026. The company says the clinic offers vein screenings and diagnostic evaluations, among other services, expanding access across eastern Hillsborough County.
United Vein & Vascular Centers
United Vein & Vascular Centers Brings Specialized Vein Care to Vero Beach's Medical District
United Vein & Vascular Centers also opened a vein clinic at 3755 7th Terrace, Suite 202, Vero Beach, FL 32960, in the city's medical district, which began seeing patients on Oct. 26, 2026. The company says it offers vein screenings and diagnostic evaluations, among other services.
VANTIVE US HEALTHCARE LLC
Vantive Announces Expansion of HomeAdvantage and Highlights New Evidence to Advance Home Dialysis During Kidney Week
Vantive says it plans to expand its HomeAdvantage offering with the next-generation Avira automated peritoneal dialysis cycler, which is progressing through health authority processes in select countries and is not yet available for sale. The company also presented new home dialysis data during Kidney Week.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not News Today Lines reporting.